Global Health Limited (NSE:MEDANTA)
India · Delayed Price · Currency is INR 1,439.90
+10.90 (0.76%)
Nov 12, 2026, 3:29 PM IST
Global Health Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 50,532 | 44,103 | 36,923 | 32,751 | 27,099 | 21,725 |
Revenue Growth | 26.18% | 19.44% | 12.74% | 20.86% | 24.74% | 49.63% |
Gross Profit Gross Profit Growth | 26,174 | 22,185 | 19,152 | 17,167 | 13,755 | 10,057 |
Operating Income Operating Income Growth | 8,554 | 7,014 | 6,850 | 6,298 | 4,844 | 3,346 |
Net Income Net Income Growth | 6,184 | 5,565 | 4,814 | 4,782 | 3,261 | 1,962 |
Earnings Per Share EPS Growth | 22.96 | 20.66 | 17.92 | 17.80 | 12.57 | 7.77 |
EPS Growth | 9.94% | 15.29% | 0.67% | 41.61% | 61.78% | 581.58% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 14,008 | 11,060 | 10,507 | 11,561 | 12,604 | 4,878 |
Total Debt Total Debt Growth | 13,527 | 11,900 | 7,177 | 8,019 | 11,220 | 11,089 |
Net Cash (Debt) Net Cash Growth | 481.13 | -840.45 | 3,330 | 3,543 | 1,384 | -6,211 |
Net Cash Growth | -82.52% | - | -6.00% | 155.89% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.79 | -3.12 | 12.40 | 13.19 | 5.34 | -24.61 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 9,537 | 7,144 | 6,238 | 6,121 | 6,445 | 3,113 |
Capital Expenditures CapEx Growth | -7,646 | -8,382 | -5,165 | -2,786 | -2,360 | -2,745 |
Free Cash Flow Free Cash Flow Growth | 1,891 | -1,238 | 1,072 | 3,335 | 4,085 | 367.87 |
Free Cash Flow Growth | - | - | -67.85% | -18.37% | 1010.54% | -61.69% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 51.80% | 50.30% | 51.87% | 52.42% | 50.76% | 46.29% |
Operating Margin | 16.93% | 15.90% | 18.55% | 19.23% | 17.87% | 15.40% |
Pretax Margin | 16.13% | 16.21% | 17.53% | 19.15% | 16.58% | 12.91% |
Profit Margin | 12.24% | 12.62% | 13.04% | 14.60% | 12.03% | 9.03% |
FCF Margin | 3.74% | -2.81% | 2.90% | 10.18% | 15.08% | 1.69% |
Fiscal Year | Current | FY 2026 | FY 2025 |
|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.500 |
Dividend Per Share Growth | 0% | 0% | - |
Dividend Yield | 0.03% | 0.05% | 0.04% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 62.71 | 46.43 | 66.85 | 74.18 | 43.34 | - |
Forward PE | 45.20 | 39.25 | 52.37 | 59.16 | 39.58 | - |
P/FCF Ratio | 204.78 | - | 300.19 | 106.37 | 34.59 | - |
PS Ratio | 7.66 | 5.86 | 8.72 | 10.83 | 5.22 | - |